Stockreport

How A Short-Seller's Damning Report Sent This Cancer Biotech Tumbling [Investor's Business Daily]

Mirati Therapeutics, Inc.  (MRTX) 
Last mirati therapeutics, inc. earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mirati.com/node/5806
PDF Mirati Therapeutics crumbled Tuesday after Kerrisdale Capital shorted MRTX stock on doubts surrounding the company's key cancer treatment. The drug would inhibit a known [Read more]